Pro Medicus Ltd (ASX:PME)
A$ 115.7 0.15 (0.13%) Market Cap: 12.08 Bil Enterprise Value: 11.95 Bil PE Ratio: 170.03 PB Ratio: 74.31 GF Score: 93/100

Half Year 2021 Pro Medicus Ltd Earnings Call Transcript

Feb 17, 2021 / 12:00AM GMT
Release Date Price: A$44.69 (-2.10%)
Operator

Thank you for standing by, and welcome to the Pro Medicus PME Half Year Results Briefing Conference Call. (Operator Instructions)

I would now like to hand the conference over to Dr. Sam Hupert, CEO. Please go ahead.

Sam Aaron Hupert
Pro Medicus Limited - Co-Founder, CEO, MD & Executive Director

Thank you, and good morning, everybody, and thanks for joining us. The -- Pro Medicus, we have 3 jurisdictions we work in: our corporate headquarters in Melbourne, Australia; our largest office, Berlin, where we do the R&D for the Visage 7 product; and our quarters in San Diego in the U.S., with most of our staff working from home at the moment. Globally, we are 100% working from home. And the important thing for us is we have over 40 software engineers, very much an R&D-focused technology company.

In terms of our product sets, for those not familiar, we have 2 products: the Visage RIS, which was our first product, which deals with the practice management aspects of the radiology practice, which is largely sold here, and 2 of the largest

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot